DenComm-preview

Dencomm

DenComm

Private

SeoulHealthcare & Life Scienceshttps://dencomm.ai/

Last Round

Series A

Extension

Feb 22, 2024

Est. Valuation

$21M

Total Funding Raised

$12M

Company Overview

DenComm is an artificial intelligence company that has developed Densper, an AI voice recognition engine tailored specifically for dental practices.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Vertical SaaS, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

dental voice recognitiondental voice assistantvoice chartinghands-free chartingdental SaaSAI dental chartingdental speech-to-textmedical AIvoice controlled imagingvertical SaaSdental workflow automationdental techdental data platformdental API

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DenComm Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DenComm Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Feb 22, 2024
Series A	Nov 1, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Jaeyeon Jang

CTO

Executive Team

DenComm Investors

Notable investors and investment history

Investor	Rounds
DSC Investment	Series A Extension
TS Investment	Series A Extension, Series A
ST Asset Management Co.	Series A Extension
KB Securities	Series A Extension
Hana Securities	Series A Extension
Midasdong-a Investment	Series A
Maple Investment Partners	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 13, 2026
Grew 30% QoQ from 10 to 13 employees.
Feb 11, 2026
Grew 33% QoQ from 9 to 12 employees.

View all signals

DenComm Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DenComm Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DenComm's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range11

Year Founded2017

Last FundingFeb 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.